This website is intended to provide information to an
international audience outside the USA and UK.

• Contact Us |
• Site map

© 2010, Bayer Schering Pharma AG
This website is intended to provide information to an international audience outside the USA and UK.
Last updated on 1st September 2010

This website is intended to provide information to an
international audience outside the USA and UK.

• Site map

• About Xarelto
  • Xarelto: SPC
  • Efficacy
  • Reassuring Safety
  • Convenient Oral Therapy
  • Xarelto in Practice - Q&A
  • Health Economics
  • For the Patient

  

  Examine impressive results for simple, uncomplicated clot prevention
• Clinical Studies
  • Major Orthopaedic Surgery
  • Stroke Prevention in Atrial Fibrillation
  • Medically Ill
  • VTE Treatment
  • Secondary Prevention in Acute Coronary Syndrome

  

  See extensive results for the most studied anticoagulant of its kind
• Targeting Factor Xa
  • The Central Role of Factor Xa
  • The Coagulation Cascade
  • Xarelto - Excellent Efficacy and Convenience with Reassuring Safety

  

  View the direct inhibition of Factor Xa, an active area of research
• Thrombosis Risk
  • When Thrombosis Occurs
  • VTE - A Serious Threat
  • Stroke Prevention in Atrial Fibrillation
  • Acute Coronary Syndrome

  

  Thromboembolic disorders pose life threatening risks to millions of patients
• Resources
  • Publications
  • Xarelto News
  • Benefit Calculator
  • Downloads
  • Other Websites of Interest
  • Events Calendar
  • For the Press

  

  Connect with a world of events devoted to thromboembolic research
• XareltoTUBE
  • Xarelto Videos
  • Thrombosis Videos
  • All Videos
  • Interactive Tools

  

  Learn more about ‘Xarelto’ and Thrombosis by watching videos and using interactive tools

• Search
• Contact us

You need to install Flash version 9 to watch this movie. Click here to install it